RISK Cohort Study in Crohn's Disease

RISK Cohort Study in Crohn's Disease

RISK Cohort Study in Crohn's Disease
RestartResume
    Lu Ann Cahn talks w/ Dr. Piccoli about the RISK study that enrolled 1,800 patients & collected a variety of info to learn more about the immune system
    • Overview

      From the 42nd Annual Renaissance Ball in Philadelphia benefiting the Crohn's & Colitis Foundation, host      Lu Ann Cahn talks with Dr. David Piccoli, Chief of the Division of Gastroenterology, Hepatology and Nutrition, Director of the Biesecker PediatricLiver Center, and a board-certified pediatric gastroenterologist at Children's Hospital of Philadelphia. Dr. Piccoli discusses the RISK study, supported by the Crohn’s & Colitis Foundation, and the challenges patients face with response to treatment. This pediatric study enrolled 1,800 patients at the time of their diagnosis and collected clinical, genetic, treatment and microbiome information to help to determine how the immune system works over time.

    Facebook Comments

    Sign-up for the Prova Education newsletters.

    Better education for a better you.

    * Required
    Optional